Vertex Pharmaceuticals Incorporated Common Stock (1VRTX)
MTA
Real-time Data
07:00 AM
Day's Range
445.9052 wk Range
342.00Overview - 1VRTX - Vertex Pharmaceuticals Incorporated Common Stock
Key Statistics
Valuation
Enterprise Value
96.37B
P/E (Trailing)
‪30.39‬
PEG Ratio
‪3.81‬
Price / Sales (TTM)
‪9.19‬
Price / Book
‪6.49‬
EV / EBITDA
‪21.53‬
Profitability
Gross Margin
‪85.32%‬
Profit Margin
‪34.99%‬
Operating Margin
‪38.05%‬
Return on Assets
‪11.92%‬
Return on Equity
‪23.54%‬
Ownership
Shares Outstanding
253.34M
Float
252.68M
Held by Insiders
‪0.21%‬
Held by Institutions
‪97.96%‬
Price stats
Beta
‪0.32‬
50-Day Avg
‪447.11‬
200-Day Avg
‪407.86‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1VRTX - Vertex Pharmaceuticals Incorporated Common Stock
Peers - 1VRTX - Vertex Pharmaceuticals Incorporated Common Stock
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1VRTXMTAVertex Pharmaceuticals Incorporated Common Stock107.27BMarket Cap+27.72%52-week change30.40P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals, Inc.73.52BMarket Cap+30.66%52-week change19.47P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals, Inc.45.81BMarket Cap-73.35%52-week change43.84P/E (Trailing)‪16.12%‬Profit Margin
- 1INSMMTAInsmed Incorporated30.28BMarket Cap-19.46%52-week change-16.17P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-40.10%52-week change42.38P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corp.17.89BMarket Cap+32.92%52-week change15.77P/E (Trailing)‪27.70%‬Profit Margin
- 1RVMDMTARevolution Medicines, Inc.12.75BMarket Cap+72.89%52-week change-28.65P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 1VRTX - Vertex Pharmaceuticals Incorporated Common Stock
About
Vertex Pharmaceuticals Incorporated Common Stock represents ownership in Vertex Pharmaceuticals Incorporated, a global biotechnology company focused on discovering, developing, manufacturing, and commercializing medicines for serious diseases. The company’s current portfolio is centered on cystic fibrosis therapies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
